TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 78,000 | $697,320 | 0.31% |
| Affinity Asset Advisors, LLC | 100,000 | $894,000 | 0.25% |
| Woodline Partners LP | 2,150,565 | $19,226,051 | 0.22% |
| Palo Alto Investors LP | 166,069 | $1,484,657 | 0.14% |
| Corton Capital Inc. | 29,796 | $266,376 | 0.13% |
| Perceptive Advisors | 400,000 | $3,576,000 | 0.12% |
| Virtus ETF Advisers LLC | 17,981 | $160,750 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,671,770 | $14,945,624 | 0.09% |
| OAK RIDGE INVESTMENTS LLC | 74,314 | $664,367 | 0.08% |
| Jump Financial, LLC | 188,925 | $1,688,990 | 0.06% |
| Crestline Management, LP | 61,421 | $549,104 | 0.06% |
| Caption Management, LLC | 417,000 | $3,727,980 | 0.06% |
| XTX Topco Ltd | 35,292 | $315,510 | 0.05% |
| MACQUARIE GROUP LTD | 4,671,859 | $41,766,000 | 0.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 40,000 | $357,600 | 0.05% |
| Caption Management, LLC | 340,000 | $3,039,600 | 0.05% |
| J. Goldman & Co LP | 146,742 | $1,311,873 | 0.05% |
| RICE HALL JAMES & ASSOCIATES, LLC | 78,362 | $700,556 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 75,873 | $678,305 | 0.04% |
| TWINBEECH CAPITAL LP | 228,786 | $2,045,347 | 0.04% |
External links
This page lists TRAVERE THERAPEUTICS INC's shareholders in Q3 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.